Cite
HARVARD Citation
Zhou, M. et al. (2020). Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study. BMJ open. 10 (9), p. . [Online].